Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Jubilant Pharmova Limited logo

Jubilant Pharmova Limited

JUBLPHARMA·Pharmaceuticals
  • Nifty 500

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.

162Announcements
11-09-2026Last filed
30Last 90 days

What Jubilant files

  • Others59
  • Updates41
  • Important23
  • Investor Meet16
  • Board Meeting13
  • Dividend/Bonus4
11-09-2026 · 07:43 pm

Jubilant Pharmova Limited has informed the Exchange about General Updates

Read the full announcement→
PDF
01-09-2026 · 12:47 pm

Jubilant Pharmova received a GST demand notice for Rs. 87.31 Cr (tax, interest, penalty) for FY2022-23. The company disputes the claim, calling it incorrect, and expects no financial or operational impact, planning a detailed reply.

Read the full announcement→
PDF
29-08-2026 · 11:15 pm

Jubilant Pharmova Limited has informed the Exchange about Copy of Newspaper Publication - Re-lodgement and KYC Updation

Read the full announcement→
PDF
28-08-2026 · 10:15 am

Jubilant Generics (subsidiary) received a Show Cause Notice for alleged inadmissible IGST refund, demanding Rs. 52.75 Cr GST and Rs. 52.75 Cr penalty plus interest. The company contests this, stating it's incorrect and expects no financial impact.

Read the full announcement→
PDF
26-08-2026 · 08:10 pm

Jubilant Pharmova Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 26, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

Read the full announcement→
PDF